阿片类药物治疗癌痛:理念和认知在实践中的演化  

Cancer pain treatment by opioids the evolvement of conception and cognition in practice

作　　者：李虹义[1] 刘端祺[1] 

机构地区：[1]北京军区总医院,北京100700

出　　处：《中国新药杂志》2014年第14期1651-1653,共3页Chinese Journal of New Drugs

摘　　要：本文通过文献分析认为近10多年来WHO"三阶梯癌痛治疗原则"在判断患者疼痛、指导医生用药方面至少发生了如下"演化"值得关注,即:对疼痛评估的深化;对第2阶梯用药的淡化;对某些传统代表性止痛药物(阿司匹林、可待因)的边缘化;对第2,3阶梯阿片类药物选择的多样化;使用强阿片类药物止痛有条件的全程化(用于各个阶梯);癌痛治疗使用辅助性药物的专业化。本文同时对上述"演化"的具体缘由做了较为详细的阐述。Through analysis of the literature review,the author reputes that the three-step analgesic ladder treatment for the moderate to severe cancer pain introduced by WHO has evaluated at least in such aspects in the past 10 years：deepening the pain assessment,diluting the medication in the 2nd step,marginalizing of the traditional representation of pain medications such as Aspirin and codeine,diversifying the Aspirin-type drugs in the 2nd and the 3rd steps,treating pain with strong Aspirin-type drugs conditionally in whole process,and specializing in the using of auxiliary drugs of treatment of cancer.Furthermore,the author gives the detailed elaboration of in concrete contents above evolutions in this paper.

关 键 词：癌症疼痛 阿片类药物 三阶梯止痛治疗 

分 类 号：R971[医药卫生—药品]